Hester Biosciences Ltd.

HESTERBIO

₹2183.15

11.96% (233.2)

Market Cap

₹1,857 Cr.

P/E

49.40

Key Ratios

Edit Ratio's

Market cap

1,857 Cr

49.40

Prom Holding

53.73 %

ROE (%)

8.75

ROCE (%)

9.12

Div Yield (%)

0.60

Sales

312 Cr

OPM (%)

21.16 %

Debt to Equity

0.66

Edit Ratio's

About

Hester Biosciences Limited (Hester) is the largest poultry vaccine manufacturer and one of the… Read more

Low

1247

52W Range

High

2988

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

4 Yes

Positive for this company

2 Neutral

Neutral for this company

10 No

Negative for this company

1 No Data

Insufficient data to analyse

Accounting & Shareholding

Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales
Contingent Liabilities

Unable to calculate due to limited data

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Capex vs ROCE

Roce of the company has decreased even without significant capex
Debt

Company might have issues servicing its debt
Share price

Share price has increased over last 10 years but more due to rerating
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Market Share

35 %

(as of Mar 25)

Source/Historic

Poultry Vaccines - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Distribution Channel

Operating Profit Break-Up

Capex

Asset Break-Up - Segment

Operational Metrics

R&D as a % of Total Sales (%)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Hester Biosciences Ltd. Business

What does Hester Biosciences do?

Hester Biosciences Limited, a premier animal healthcare company in India known for poultry vaccines. Established in 1987, it has become a top global manufacturer with Asia's largest animal biological manufacturing unit in Ahmedabad.

Who are the competitors of Hester Biosciences?

Hester Biosciences major competitors are SMS Pharmaceuticals, Bajaj Healthcare, Themis Medicare, NGL Fine-Chem, Solara Active Pharma, IOL Chem & Pharma, Kopran.
Market Cap of Hester Biosciences is ₹1,857 Crs.
While the median market cap of its peers are ₹1,480 Crs.

Is Hester Biosciences financially stable compared to its competitors?

Hester Biosciences seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	May	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec	Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec		Sep
Investor Presentation								Mar		Mar	Mar
Conference Call	Mar	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Hester Biosciences Ltd.

View the discussion on ValuePickr

Business Analysis - Hester Biosciences - Value Educator

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Hester Biosciences Ltd.

Hester Biosciences Ltd.

Key Ratios

About

Timeline

Company Timeline

4 Yes

2 Neutral

10 No

1 No Data

Accounting & Shareholding

Other Income

Pledge

Promoter Holding

Depreciation Effect

Retail Holding

Revenue Recognition

Contingent Liabilities

Price & Performance

ROE

Current vs Historic Valuation

Balance Sheet Strength

Capex vs ROCE

Debt

Share price

Working Capital

Sales Growth

Margin Stability

ROCE Strength

Product Wise Break-Up

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Distribution Channel

UNLOCK PREMIUM

Operating Profit Break-Up

UNLOCK PREMIUM

Capex

UNLOCK PREMIUM

Asset Break-Up - Segment

UNLOCK PREMIUM

What does Hester Biosciences do?

Who are the competitors of Hester Biosciences?

Is Hester Biosciences financially stable compared to its competitors?

SIGN UP FOR FREE